The No-Go and Nonsense-Mediated RNA Decay
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets Snorna Host Genes
Downloaded from genesdev.cshlp.org on October 2, 2021 - Published by Cold Spring Harbor Laboratory Press Human nonsense-mediated RNA decay initiates widely by endonucleolysis and targets snoRNA host genes Søren Lykke-Andersen,1,4 Yun Chen,2,4 Britt R. Ardal,1 Berit Lilje,2 Johannes Waage,2,3 Albin Sandelin,2 and Torben Heick Jensen1 1Centre for mRNP Biogenesis and Metabolism, Department of Molecular Biology and Genetics, Aarhus University, Aarhus DK-8000, Denmark; 2The Bioinformatics Centre, Department of Biology and Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen DK-2200, Denmark Eukaryotic RNAs with premature termination codons (PTCs) are eliminated by nonsense-mediated decay (NMD). While human nonsense RNA degradation can be initiated either by an endonucleolytic cleavage event near the PTC or through decapping, the individual contribution of these activities on endogenous substrates has remained unresolved. Here we used concurrent transcriptome-wide identification of NMD substrates and their 59–39 decay intermediates to establish that SMG6-catalyzed endonucleolysis widely initiates the degradation of human nonsense RNAs, whereas decapping is used to a lesser extent. We also show that a large proportion of genes hosting snoRNAs in their introns produce considerable amounts of NMD-sensitive splice variants, indicating that these RNAs are merely by-products of a primary snoRNA production process. Additionally, transcripts from genes encoding multiple snoRNAs often yield alternative transcript isoforms that allow for differential expression of individual coencoded snoRNAs. Based on our findings, we hypothesize that snoRNA host genes need to be highly transcribed to accommodate high levels of snoRNA production and that the expression of individual snoRNAs and their cognate spliced RNA can be uncoupled via alternative splicing and NMD. -
A Genome-Wide Association Study of a Coronary Artery Disease Risk Variant
Journal of Human Genetics (2013) 58, 120–126 & 2013 The Japan Society of Human Genetics All rights reserved 1434-5161/13 www.nature.com/jhg ORIGINAL ARTICLE A genome-wide association study of a coronary artery diseaseriskvariant Ji-Young Lee1,16, Bok-Soo Lee2,16, Dong-Jik Shin3,16, Kyung Woo Park4,16, Young-Ah Shin1, Kwang Joong Kim1, Lyong Heo1, Ji Young Lee1, Yun Kyoung Kim1, Young Jin Kim1, Chang Bum Hong1, Sang-Hak Lee3, Dankyu Yoon5, Hyo Jung Ku2, Il-Young Oh4, Bong-Jo Kim1, Juyoung Lee1, Seon-Joo Park1, Jimin Kim1, Hye-kyung Kawk1, Jong-Eun Lee6, Hye-kyung Park1, Jae-Eun Lee1, Hye-young Nam1, Hyun-young Park7, Chol Shin8, Mitsuhiro Yokota9, Hiroyuki Asano10, Masahiro Nakatochi11, Tatsuaki Matsubara12, Hidetoshi Kitajima13, Ken Yamamoto13, Hyung-Lae Kim14, Bok-Ghee Han1, Myeong-Chan Cho15, Yangsoo Jang3,17, Hyo-Soo Kim4,17, Jeong Euy Park2,17 and Jong-Young Lee1,17 Although over 30 common genetic susceptibility loci have been identified to be independently associated with coronary artery disease (CAD) risk through genome-wide association studies (GWAS), genetic risk variants reported to date explain only a small fraction of heritability. To identify novel susceptibility variants for CAD and confirm those previously identified in European population, GWAS and a replication study were performed in the Koreans and Japanese. In the discovery stage, we genotyped 2123 cases and 3591 controls with 521 786 SNPs using the Affymetrix SNP Array 6.0 chips in Korean. In the replication, direct genotyping was performed using 3052 cases and 4976 controls from the KItaNagoya Genome study of Japan with 14 selected SNPs. -
Quality Control of Eukaryotic Mrna: Safeguarding Cells from Abnormal Mrna Function
Downloaded from genesdev.cshlp.org on October 2, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW Quality control of eukaryotic mRNA: safeguarding cells from abnormal mRNA function Olaf Isken and Lynne E. Maquat1 Department of Biochemistry and Biophysics, School of Medicine and Dentistry, University of Rochester, Rochester, New York 14642, USA Cells routinely make mistakes. Some mistakes are en- (Dreyfuss et al. 2002). RNA-associated proteins not only coded by the genome and may manifest as inherited or reflect the history of the RNA but may also influence acquired diseases. Other mistakes occur because meta- future steps of RNA metabolism (Giorgi and Moore bolic processes can be intrinsically inefficient or inaccu- 2007). rate. Consequently, cells have developed mechanisms to Cells have evolved pathways to eliminate RNAs that minimize the damage that would result if mistakes went are incorrectly processed or improperly function either unchecked. Here, we provide an overview of three qual- because of mutations within the genes that encode them ity control mechanisms—nonsense-mediated mRNA de- or because of mistakes made during their metabolism cay, nonstop mRNA decay, and no-go mRNA decay. and/or function in the absence of mutations within their Each surveys mRNAs during translation and degrades genes. This review will focus on pathways that eliminate those mRNAs that direct aberrant protein synthesis. defective mRNAs as a consequence of their inability to Along with other types of quality control that occur dur- properly direct protein synthesis. These pathways en- ing the complex processes of mRNA biogenesis, these compass the translation-dependent mechanisms of mRNA surveillance mechanisms help to ensure the in- cytoplasmic surveillance. -
Genome-Wide Transcriptional Sequencing Identifies Novel Mutations in Metabolic Genes in Human Hepatocellular Carcinoma DAOUD M
CANCER GENOMICS & PROTEOMICS 11 : 1-12 (2014) Genome-wide Transcriptional Sequencing Identifies Novel Mutations in Metabolic Genes in Human Hepatocellular Carcinoma DAOUD M. MEERZAMAN 1,2 , CHUNHUA YAN 1, QING-RONG CHEN 1, MICHAEL N. EDMONSON 1, CARL F. SCHAEFER 1, ROBERT J. CLIFFORD 2, BARBARA K. DUNN 3, LI DONG 2, RICHARD P. FINNEY 1, CONSTANCE M. CULTRARO 2, YING HU1, ZHIHUI YANG 2, CU V. NGUYEN 1, JENNY M. KELLEY 2, SHUANG CAI 2, HONGEN ZHANG 2, JINGHUI ZHANG 1,4 , REBECCA WILSON 2, LAUREN MESSMER 2, YOUNG-HWA CHUNG 5, JEONG A. KIM 5, NEUNG HWA PARK 6, MYUNG-SOO LYU 6, IL HAN SONG 7, GEORGE KOMATSOULIS 1 and KENNETH H. BUETOW 1,2 1Center for Bioinformatics and Information Technology, National Cancer Institute, Rockville, MD, U.S.A.; 2Laboratory of Population Genetics, National Cancer Institute, National Cancer Institute, Bethesda, MD, U.S.A.; 3Basic Prevention Science Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, U.S.A; 4Department of Biotechnology/Computational Biology, St. Jude Children’s Research Hospital, Memphis, TN, U.S.A.; 5Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea; 6Department of Internal Medicine, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan, Korea; 7Department of Internal Medicine, College of Medicine, Dankook University, Cheon-An, Korea Abstract . We report on next-generation transcriptome Worldwide, liver cancer is the fifth most common cancer and sequencing results of three human hepatocellular carcinoma the third most common cause of cancer-related mortality (1). tumor/tumor-adjacent pairs. -
A Protein with Similarities to Caenorhabditis Elegans SMG5 and SMG7 That Functions in the Dephosphorylation of Upf1
Downloaded from rnajournal.cshlp.org on October 5, 2021 - Published by Cold Spring Harbor Laboratory Press Characterization of human Smg5/7a: A protein with similarities to Caenorhabditis elegans SMG5 and SMG7 that functions in the dephosphorylation of Upf1 SHANG-YI CHIU,1 GUILLAUME SERIN,1,3 OSAMU OHARA,2 and LYNNE E. MAQUAT1 1Department of Biochemistry and Biophysics, School of Medicine and Dentistry, University of Rochester, Rochester, New York 14642, USA 2Department of Human Gene Research, Kazusa DNA Research Institute, Kisarazu, Chiba 292-0812, Japan; Immunogenomics Research Team, RIKEN Research Center for Allergy and Immunology, Yokohama, Japan ABSTRACT Nonsense-mediated mRNA decay (NMD) in mammalian cells depends on phosphorylation of Upf1, an RNA-dependent ATPase and 5-to-3 helicase. Upf1 phosphorylation is mediated by Smg1, a phosphoinositol 3-kinase–related protein kinase. Here, we describe a human protein, which we call hSmg5/7a, that manifests similarity to Caenorhabditis elegans NMD factors CeSMG5 and CeSMG7, as well as two Drosophila melanogaster proteins that are also similar to the C. elegans NMD factors. Results indicate that hSmg5/7a functions in the dephosphorylation of Upf1. Furthermore, hSmg5/7a copurifies with Upf1, Upf2, Upf3X, Smg1, and the catalytic subunit of protein phosphatase 2A. We also demonstrate that Upf2, another factor involved in NMD, is a phosphoprotein. However, hSmg5/7a plays no role in the dephosphorylation of Upf2. These data indicate that hSmg5/7a targets protein phosphatase 2A to Upf1 but not -
TERRA: Telomeric Repeat-Containing RNA
The EMBO Journal (2009) 28, 2503–2510 | & 2009 European Molecular Biology Organization | Some Rights Reserved 0261-4189/09 www.embojournal.org TTHEH E EEMBOMBO JJOURNALOURN AL Focus Review TERRA: telomeric repeat-containing RNA Brian Luke1,2 and Joachim Lingner1,2,* lytic processing of chromosome ends and the end replication problem. This shortening can be counteracted by the cellular 1EPFL-Ecole Polytechnique Fe´de´rale de Lausanne, ISREC-Swiss Institute for Experimental Cancer Research, Lausanne, Switzerland and reverse-transcriptase telomerase, which uses an internal RNA 2‘Frontiers in Genetics’ National Center for Competence in Research moiety as a template for the synthesis of telomere repeats (NCCR), Geneva, Switzerland (Cech, 2004; Blackburn et al, 2006). Telomerase is regulated at individual chromosome ends through telomere-binding Telomeres, the physical ends of eukaryotic chromosomes, proteins to mediate telomere length homoeostasis; however, consist of tandem arrays of short DNA repeats and a large in humans, telomerase is expressed in most tissues only set of specialized proteins. A recent analysis has identified during the first weeks of embryogenesis (Ulaner and telomeric repeat-containing RNA (TERRA), a large non- Giudice, 1997). Repression of telomerase in somatic cells is coding RNA in animals and fungi, which forms an integral thought to result in a powerful tumour-suppressive function. component of telomeric heterochromatin. TERRA tran- Short telomeres that accumulate following an excessive scription occurs at most or all chromosome ends and it number of cell division cycles induce cellular senescence, is regulated by RNA surveillance factors and in response to and this counteracts the growth of pre-malignant lesions. -
Common Genetic Variants and Subclinical Atherosclerosis: the Multi-Ethnic Study of Atherosclerosis
Common Genetic Variants and Subclinical Atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA). Authors Authors: Jose D. Vargas, Ani Manichaikul, Xin Q. Wang, Stephen S. Rich, Jerome I. Rotter, Wendy S. Post, Joseph F. Polak, Matthew J. Budoff, and David A. Bluemke. Abstract Background: Subclinical atherosclerosis (sCVD), measured by coronary artery calcium (CAC) and carotid intima media thickness (CIMT) has been associated with cardiovascular disease (CVD). Genome Wide Association Studies (GWAS) of CVD have focused on Caucasian populations. We hypothesized that these associations would differ in populations from distinct genetic backgrounds. Methods and Results: The associations between sCVD and 66 single nucleotide polymorphisms (SNPs) from published GWAS of sCVD and CVD were tested in 8224 Multi-Ethnic Study of Atherosclerosis (MESA) and MESA Family participants (2685 Caucasians (EUA), 777 Chinese (CHN), 2588 African Americans (AFA), and 2174 Hispanic (HIS)) using an additive model adjusting for CVD risk factors, with SNP significance defined by a Bonferroni-corrected p < 7.6 x 10-4 (0.05/66). Results: In EUA there were significant associations with CAC in 9p21 (rs1333049, P=2 x 10-9; rs4977574, P= 4 x 10-9), COL4A1 (rs9515203, P=9 x 10-6), and PHACTR1 (rs9349379, P= 4 x 10-4). In HIS, SNPs were associated with CAC in 9p21 (rs1333049, P=8 x 10-5; rs4977574, P=5 x 10-5), APOA5 (rs964184, P=2 x 10-4), and ADAMTS7 (rs7173743, P=4 x 10-4). There were no associations with the 9p21 region in AFA and CHN. Fine mapping of the 9p21 region revealed SNPs with robust associations with CAC in EUA and HIS but no significant associations in AFA and CHN. -
Autoregulation of the Nonsense-Mediated Mrna Decay Pathway in Human Cells
Downloaded from rnajournal.cshlp.org on October 1, 2021 - Published by Cold Spring Harbor Laboratory Press Autoregulation of the nonsense-mediated mRNA decay pathway in human cells HASMIK YEPISKOPOSYAN,1 FLORIAN AESCHIMANN,1 DANIEL NILSSON,2 MICHAL OKONIEWSKI,3 and OLIVER MU¨ HLEMANN1,4 1Department of Chemistry and Biochemistry, University of Bern, 3012 Bern, Switzerland 2Science for Life Laboratory, Clinical Genetics Unit L5:03, Karolinska University Hospital, Solna 171 76, Stockholm, Sweden 3Functional Genomics Center, University of Zurich and Swiss Federal Institute of Technology, 8057 Zurich, Switzerland ABSTRACT Nonsense-mediated mRNA decay (NMD) is traditionally portrayed as a quality-control mechanism that degrades mRNAs with truncated open reading frames (ORFs). However, it is meanwhile clear that NMD also contributes to the post-transcriptional gene regulation of numerous physiological mRNAs. To identify endogenous NMD substrate mRNAs and analyze the features that render them sensitive to NMD, we performed transcriptome profiling of human cells depleted of the NMD factors UPF1, SMG6, or SMG7. It revealed that mRNAs up-regulated by NMD abrogation had a greater median 39-UTR length compared with that of the human mRNAome and were also enriched for 39-UTR introns and uORFs. Intriguingly, most mRNAs coding for NMD factors were among the NMD-sensitive transcripts, implying that the NMD process is autoregulated. These mRNAs all possess long 39 UTRs, and some of them harbor uORFs. Using reporter gene assays, we demonstrated that the long 39 UTRs of UPF1, SMG5, and SMG7 mRNAs are the main NMD-inducing features of these mRNAs, suggesting that long 39 UTRs might be a frequent trigger of NMD. -
UC Berkeley UC Berkeley Electronic Theses and Dissertations
UC Berkeley UC Berkeley Electronic Theses and Dissertations Title Networks of Splice Factor Regulation by Unproductive Splicing Coupled With NMD Permalink https://escholarship.org/uc/item/4md923q7 Author Desai, Anna Publication Date 2017 Peer reviewed|Thesis/dissertation eScholarship.org Powered by the California Digital Library University of California Networks of Splice Factor Regulation by Unproductive Splicing Coupled With NMD by Anna Maria Desai A dissertation submitted in partial satisfaction of the requirements for the degree of Doctor of Philosophy in Comparative Biochemistry in the Graduate Division of the University of California, Berkeley Committee in charge: Professor Steven E. Brenner, Chair Professor Donald Rio Professor Lin He Fall 2017 Abstract Networks of Splice Factor Regulation by Unproductive Splicing Coupled With NMD by Anna Maria Desai Doctor of Philosophy in Comparative Biochemistry University of California, Berkeley Professor Steven E. Brenner, Chair Virtually all multi-exon genes undergo alternative splicing (AS) to generate multiple protein isoforms. Alternative splicing is regulated by splicing factors, such as the serine/arginine rich (SR) protein family and the heterogeneous nuclear ribonucleoproteins (hnRNPs). Splicing factors are essential and highly conserved. It has been shown that splicing factors modulate alternative splicing of their own transcripts and of transcripts encoding other splicing factors. However, the extent of this alternative splicing regulation has not yet been determined. I hypothesize that the splicing factor network extends to many SR and hnRNP proteins, and is regulated by alternative splicing coupled to the nonsense mediated mRNA decay (NMD) surveillance pathway. The NMD pathway has a role in preventing accumulation of erroneous transcripts with dominant negative phenotypes. -
UPF1: from Mrna Surveillance to Protein Quality Control
biomedicines Review UPF1: From mRNA Surveillance to Protein Quality Control Hyun Jung Hwang 1,2, Yeonkyoung Park 1,2 and Yoon Ki Kim 1,2,* 1 Creative Research Initiatives Center for Molecular Biology of Translation, Korea University, Seoul 02841, Korea; [email protected] (H.J.H.); [email protected] (Y.P.) 2 Division of Life Sciences, Korea University, Seoul 02841, Korea * Correspondence: [email protected] Abstract: Selective recognition and removal of faulty transcripts and misfolded polypeptides are crucial for cell viability. In eukaryotic cells, nonsense-mediated mRNA decay (NMD) constitutes an mRNA surveillance pathway for sensing and degrading aberrant transcripts harboring premature termination codons (PTCs). NMD functions also as a post-transcriptional gene regulatory mechanism by downregulating naturally occurring mRNAs. As NMD is activated only after a ribosome reaches a PTC, PTC-containing mRNAs inevitably produce truncated and potentially misfolded polypeptides as byproducts. To cope with the emergence of misfolded polypeptides, eukaryotic cells have evolved sophisticated mechanisms such as chaperone-mediated protein refolding, rapid degradation of misfolded polypeptides through the ubiquitin–proteasome system, and sequestration of misfolded polypeptides to the aggresome for autophagy-mediated degradation. In this review, we discuss how UPF1, a key NMD factor, contributes to the selective removal of faulty transcripts via NMD at the molecular level. We then highlight recent advances on UPF1-mediated communication between mRNA surveillance and protein quality control. Keywords: nonsense-mediated mRNA decay; UPF1; aggresome; CTIF; mRNA surveillance; protein quality control Citation: Hwang, H.J.; Park, Y.; Kim, Y.K. UPF1: From mRNA Surveillance to Protein Quality Control. Biomedicines 2021, 9, 995. -
Genetic Screens Identify Connections Between Ribosome Recycling And
bioRxiv preprint doi: https://doi.org/10.1101/2021.08.03.454884; this version posted August 3, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Full Title: Genetic screens identify connections between ribosome 2 recycling and nonsense mediated decay 3 4 Short Title: A relationship between ribosome recycling and nonsense 5 mediated decay 6 7 Authors: Karole N. D’Orazio1, Laura N. Lessen1, Anthony J. Veltri1, Zachary 8 Neiman1, Miguel Pacheco1, Raphael Loll-Krippleber2, Grant W. Brown2, Rachel 9 Green1 10 11 Affiliations: 12 1Howard Hughes Medical Institute, Department of Molecular Biology and 13 Genetics, Johns Hopkins University School of Medicine, Baltimore, MD 21205, 14 USA 15 16 2Department of Biochemistry and Donnelly Centre, University of Toronto, 17 Toronto, ON M5S 3E1, Canada 18 19 *Correspondence to: [email protected] 20 21 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.08.03.454884; this version posted August 3, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 22 Abstract: 23 The decay of messenger RNA with a premature termination codon (PTC) by 24 nonsense mediated decay (NMD) is an important regulatory pathway for 25 eukaryotes and an essential pathway in mammals. NMD is typically triggered by 26 the ribosome terminating at a stop codon that is aberrantly distant from the poly- 27 A tail. -
Identifying Genetic Risk Variants for Coronary Heart Disease in Familial Hypercholesterolemia: an Extreme Genetics Approach
European Journal of Human Genetics (2015) 23, 381–387 & 2015 Macmillan Publishers Limited All rights reserved 1018-4813/15 www.nature.com/ejhg ARTICLE Identifying genetic risk variants for coronary heart disease in familial hypercholesterolemia: an extreme genetics approach Jorie Versmissen1,31, Danie¨lla M Oosterveer1,31, Mojgan Yazdanpanah1,31, Abbas Dehghan2, Hilma Ho´lm3, Jeanette Erdman4, Yurii S Aulchenko2,5, Gudmar Thorleifsson3, Heribert Schunkert4, Roeland Huijgen6, Ranitha Vongpromek1, Andre´ G Uitterlinden1,2, Joep C Defesche6, Cornelia M van Duijn2, Monique Mulder1, Tony Dadd7, Hro´bjartur D Karlsson8, Jose Ordovas9, Iris Kindt10, Amelia Jarman7, Albert Hofman2, Leonie van Vark-van der Zee1, Adriana C Blommesteijn-Touw1, Jaap Kwekkeboom11, Anho H Liem12, Frans J van der Ouderaa13, Sebastiano Calandra14, Stefano Bertolini15, Maurizio Averna16, Gisle Langslet17, Leiv Ose17, Emilio Ros18,19,Fa´tima Almagro20, Peter W de Leeuw21, Fernando Civeira22, Luis Masana23, Xavier Pinto´ 24, Maarten L Simoons25, Arend FL Schinkel1,25, Martin R Green7, Aeilko H Zwinderman26, Keith J Johnson27, Arne Schaefer28, Andrew Neil29, Jacqueline CM Witteman2, Steve E Humphries30, John JP Kastelein6 and Eric JG Sijbrands*,1 Mutations in the low-density lipoprotein receptor (LDLR) gene cause familial hypercholesterolemia (FH), a disorder characterized by coronary heart disease (CHD) at young age. We aimed to apply an extreme sampling method to enhance the statistical power to identify novel genetic risk variants for CHD in individuals with FH. We selected cases and controls with an extreme contrast in CHD risk from 17 000 FH patients from the Netherlands, whose functional LDLR mutation was unequivocally established. The genome-wide association (GWA) study was performed on 249 very young FH cases with CHD and 217 old FH controls without CHD (above 65 years for males and 70 years of age for females) using the Illumina HumanHap550K chip.